Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
Albert HenryMaria Gordillo-MarañónChris FinanAmand F SchmidtJoao Pedro FerreiraRavi KarraJohan SundströmLars LindJohan ÄrnlövFaiez ZannadAnders MälarstigAroon D HingoraniR Thomas Lumbersnull nullPublished in: Circulation (2022)
We identified 44 circulating proteins that were associated with incident HF, of which 8 showed evidence of a causal relationship and 7 were druggable, including adrenomedullin, which represents a particularly promising drug target. Our approach demonstrates a tractable roadmap for the triangulation of population genomic and proteomic data for the prioritization of therapeutic targets for complex human diseases.
Keyphrases
- heart failure
- endothelial cells
- label free
- acute heart failure
- cardiovascular disease
- mass spectrometry
- electronic health record
- induced pluripotent stem cells
- pluripotent stem cells
- left ventricular
- copy number
- big data
- emergency department
- atrial fibrillation
- adverse drug
- cardiac resynchronization therapy
- machine learning
- genome wide
- deep learning